Abstract:Despite advancements in deep learning for histopathology, integrating these insights with multi-omics data to uncover clinically relevant omics pathway-level signatures remains a challenge. Our study addresses this gap by applying unsupervised learning techniques on pan-cancer multi-omics data, leveraging 3,080 Hematoxylin and Eosin (H&E) images from 1,010 patients in Clinical Proteomic Tumor Analysis Consortium (CPTAC) to uncover omics pathway-level signatures that drive discernable morphology phenotypes at the tissue level. First, imaging models were trained to predict clinical and mutation outcomes, and thereafter, integrated with transcriptomic and proteomic expression data using sparse canonical correlation analysis. Our findings reveal that images of TP53 mutated samples exhibited increased nuclear size and dense lymphoplasmacytic infiltration. These morphological changes correlated with neutrophil and macrophage signaling at the proteomic level, and IL-1 mediated signaling at the transcriptomic level, highlighting the complementary perspectives different omics can provide. To further elucidate immune interactions, we applied multi-omics deconvolution to identify 7 immune subtypes, characterizing each with gene set enrichment, germline DNA variations, and kinase activations. We show that imaging models trained to predict these subtypes differentiate tissue morphologies corresponding to immune enrichment (AUROC: 0.84). To further confirm the robustness of our approach, we trained models to predict co-regulated proteomic modules clustered by independent component analysis. We demonstrate a signature in pan-squamous tumors, consisting of T cell markers and interferon-gamma response proteins like CD4, CD48, and GBP5, which imaging models can successfully predict from histopathology. Manual review from pathologists confirmed lymphocytic T-cell density as a differentiator in samples with the highest and lowest T-cell signaling. Together, these approaches demonstrate that genomic characteristics discovered via unbiased mining of pan-cancer multi-omics data manifest as quantitative imaging phenotypes. These results underscore the potential of multi-omics and digital pathology to integratively uncover and confirm new cancer biology. Our ongoing work will explore predicting drug response and survival from morphology patterns related to multi-omics signatures. Citation Format: Joshua Wang, Runyu Hong, Jimin Tan, Wenke Liu, David Fenyȯ. Uncovering clinically relevant omics signatures from pan-cancer imaging and multi-omics data integration [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2024; Part 1 (Regular s); 2024 Apr 5-10; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2024;84(6_Suppl) nr 888.

Integrative Analysis of Cellular Morphometric Context Reveals Clinically Relevant Signatures in Lower Grade Glioma.

Clinical Significance and Molecular Annotation of Cellular Morphometric Subtypes in Lower Grade Gliomas Discovered by Machine Learning: a Retrospective Multicentric Study

Molecular Bases of Morphometric Composition in Glioblastoma Multiforme

Morphometic Analysis of TCGA Glioblastoma Multiforme

Invariant Delineation of Nuclear Architecture in Glioblastoma Multiforme for Clinical and Molecular Association

Phenotypic Characterization of Breast Invasive Carcinoma Via Transferable Tissue Morphometric Patterns Learned from Glioblastoma Multiforme

Deep Neural Network Analysis of Pathology Images With Integrated Molecular Data for Enhanced Glioma Classification and Grading

Prognostic stratification of glioblastoma patients by unsupervised clustering of morphology patterns on whole slide images furthering our disease understanding

Integrative analysis of pathological images and multi-dimensional genomic data for early-stage cancer prognosis.

EPCO-31. AI-BASED PROGNOSTIC STRATIFICATION OF GLIOBLASTOMA USING H&E-STAINED WHOLE SLIDE IMAGES

Visual histological assessment of morphological features reflects the underlying molecular profile in invasive breast cancer: a morphomolecular study

Integrative Analysis Of Histopathological Images And Genomic Data Predicts Clear Cell Renal Cell Carcinoma Prognosis

Multimodal Data Integration Using Deep Learning Predicts Overall Survival of Patients with Glioma

Correlation Analysis of Histopathology and Proteogenomics Data for Breast Cancer

Detecting Histologic & Clinical Glioblastoma Patterns of Prognostic Relevance

Prognosis and clinical features analysis of EMT-related signature and tumor Immune microenvironment in glioma

Abstract 888: Uncovering clinically relevant omics signatures from pan-cancer imaging and multi-omics data integration

Comprehensive Molecular Analyses of a Novel Mutational Signature Classification System with Regard to Prognosis, Genomic Alterations, and Immune Landscape in Glioma

Integrating Spatial and Morphological Characteristics into Melanoma Prognosis: A Computational Approach

From Histopathology Images to Cell Clouds: Learning Slide Representations with Hierarchical Cell Transformer

Identification and validation of an anoikis-associated gene signature to predict clinical character, stemness, IDH mutation, and immune filtration in glioblastoma